Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy
NCT00166621
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDIV
Sponsor class
Conditions
Autism
Interventions
DRUG:
Buspirone
Sponsor
Chugani, Diane C.